ICGC-TCGA Somatic Mutation Calling DREAM Challenge
Learn More What is tumour heterogeneity? Tumors are composed of many different cell types, ranging from the normal tissue micro-environment, infiltrating immune
SMC-DNA Meta
Learn More The ICGC-TCGA DREAM Somatic Mutation Calling Meta-pipeline Challenge (SMC-DNA Meta) (herein, The Challenge) is an international effort to improve standard
Prostate Cancer DREAM Challenge
Learn More This challenge will attempt to improve the prediction of survival and toxicity of docetaxel treatment in patients with metastatic castration-resistant
DREAM 7 – Sage Bionetworks-DREAM Breast Cancer Prognosis Challenge
Learn More The goal of the breast cancer prognosis Challenge is to assess the accuracy of computational models designed to predict breast
Broad-DREAM Gene Essentiality Prediction
Learn More Large-scale functional screening of cancer cell lines provides a complementary approach to cancer genome studies that aim to characterize the
Acute Myeloid Leukemia Outcome Prediction Challenge
Learn More In 2014, there is projected to be 18,860 new cases of acute myeloid leukemia (AML), and 10,460 deaths from AML.
ICGC-TCGA DREAM Mutation Calling
Learn More The ICGC-TCGA DREAM Genomic Mutation Calling Challenge (herein, The Challenge) is an international effort to improve standard methods for identifying
DREAM 8 – HPN-DREAM Breast Cancer Network Inference Challenge
Learn More The overall goal of the Heritage-DREAM breast cancer network inference challenge is to quickly and effectively advance our ability to
DREAM 7 – NCI-DREAM Drug Sensitivity and Drug Synergy Challenge
Learn More Development of new cancer therapeutics currently requires a long and protracted process of experimentation and testing. Human cancer cell lines
DREAM 6 – FlowCAP2 Molecular Classification of Acute Myeloid Leukemia Challenge
Learn More The goal of this challenge is to diagnose Acute Myeloid Leukaemia from patient samples using flow cytometry data. For the